APR 25, 2019 6:00 AM PDT

Is Bacterial Vaginosis a Sexually Transmitted Infection?

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Professor of Medicine and Epidemiology, Division of Infectious Diseases, University of Alabama at Birmingham
    Biography
      Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. Her clinical and research interests focus on HIV and sexually transmitted diseases (specifically vaginal infections) among sexual minority women of color and women with increased numbers of recent sexual partners. Dr. Muzny currently has a K23 career development award from the National Institute of Allergy and Infectious Diseases to study the pathogenesis of bacterial vaginosis among African American women who have sex with women. She is currently an Associate Professor in the Division of Infectious Diseases at UAB, a teaching faculty for the Alabama-North Carolina STD/HIV Prevention Training Center, and an Associate Scientist for the UAB Center for AIDS Research.

    Abstract

    Despite over 60+ years of research, the etiology of bacterial vaginosis (BV), the most common vaginal infection, remains controversial. Epidemiological data strongly suggest that BV is acquired via sexual transmission. This presentation will review pertinent epidemiological data regarding BV, particularly as it relates to sexual transmission. It will also discuss current hypotheses regarding the etiology of BV. 

    Learning Objectives: 

    1. Review the epidemiology of bacterial vaginosis (BV), particularly as it relates to sexual transmission
    2. Discuss current hypotheses regarding the etiology of BV


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    Loading Comments...
    Show Resources
    Attendees
    • See more